A novel extended-depth-of-focus (EDOF) IOL (Mini WELL IOL, SIFI Medtech) is providing very favorable functional and safety outcomes that correspond with a high degree of patient satisfaction, according to data collected by ophthalmologist
The latest iteration of a certain IOL family (enVista, Bausch + Lomb) is receiving positive feedback from early surgical users.
Post-LASIK refraction does not appear to be altered after pregnancy, according to the results from a small study.
Treatment of ophthalmoplegia depends largely on the degree of paresis—the fewer the number of muscles that are involved and the greater the degree of residual activity in the affected muscles, the greater the likelihood of successful surg
As a first year resident, everything was new and I was full of questions. My chief resident, Reay, is famous now but back then he was just a regular guy—but a regular guy with all the answers.
In the treatment of chronic dry eye, cost and compliance with topical medications have been ongoing problems. We know t
A close relationship exists between migraine and the eye, said Kathleen B.
Two new glaucoma drugs approved in late 2017 are not on the 2018 Medicare Part D formulary, creating quandaries for physicians who would like to prescribe them and for patients who may have to pay out of pocket.